Bookmark

Add to MyYahoo RSS

Dendreon News

News on Dendreon (Ticker: DNDN) continually updated from thousands of sources around the net.

Monday | SchaeffersResearch.com

Options Check-Up: Facebook Inc (FB), Dendreon Corporation, and American Express Company

This isn't surprising considering Facebook Inc has fallen roughly 15% over the past month to trade at $58.53.

Comment?

Related Topix: Financial Services, Travelers Express Company, Day Trading, Financial Markets, Personal Finance

Fri Apr 11, 2014

Hispanic Business

Immune Responses Enhanced and Sustained When PROVENGE ...

These data will be presented at the 29th Annual .1 'We are pleased with the preliminary STAND data, which show the continued potential for sequencing PROVENGE with other treatments and the impact that immunotherapy has on immune responses in advanced prostate cancer patients,' said .

Comment?

Business Wire

Press release distribution, EDGAR filing, XBRL, regulatory filings

Immune Responses Enhanced and Sustained When PROVENGE is Given After Androgen Deprivation Therapy in Biochemically-Recurrent Prostate Cancer )--April 11, 2014 - Dendreon Corporation today announced the presentation of preliminary data from a long-term analysis of the Phase II STAND study demonstratin... )--Global alternative asset manager The ... (more)

Comment?

Related Topix: Prostate Cancer, Health, Genetics, Medicine, Biology, Science, Banking, JP Morgan Chase , Mortgage, Personal Finance

Theflyonthewall.com

Dendreon: Immune responses enhanced when Provenge given after ADT

Dendreon: Immune responses enhanced when Provenge given after ADT Dendreon Corporation announced the presentation of preliminary data from a long-term analysis of the Phase II STAND study demonstrating that tumor-specific T-cell responses appear to be enhanced and sustained when PROVENGE is given after androgen deprivation therapy in patients with ... (more)

Comment?

Related Topix: Prostate Cancer, Health

Thu Apr 10, 2014

Benzinga

Short Interest Rises As Biotechs Fall

In a period when many biotech stocks were slipping, short sellers moved on many of the leading biotech and emerging pharmaceuticals between the March 14 and March 31 settlement dates.

Comment?

Related Topix: Biotech, Science / Technology, Financial Markets, Medicine, Healthcare Industry, Seattle Genetics, Genetics, Biology, Science

Tue Mar 25, 2014

Seeking Alpha

Dendreon Ready For A Rebound

A scientific consensus is emerging that the most likely future cure for cancers will be highly specific combinations of immunotherapy and checkpoint inhibitors , tuned to the specific genetics of the individual cancer target.

Comment?

Mon Mar 24, 2014

Seeking Alpha

3 Reasons To Buy Dendreon

Biotechnology company Dendreon's performance this year hasn't been up to the mark as shares have remained flat so far.

Comment?

•••
•••
•••
•••
•••

Ashburn Jobs

•••
•••
•••
•••
•••